Search for: "AVENTIS PHARMACEUTICALS, INC.,"
Results 61 - 80
of 219
Sort by Relevance
|
Sort by Date
7 Sep 2012, 3:23 pm
Allergan USA, Inc., 2012 WL 3692396 (E.D. [read post]
9 Aug 2012, 5:00 am
Aventis (?) [read post]
13 May 2012, 4:46 pm
Hospira, Inc. [read post]
10 May 2012, 7:45 am
A Sanofi Aventis scientist has been sentenced to 18 months in prison for stealing the pharmaceutical company's trade secrets and putting them up for sale through the U.S. branch of a Chinese chemicals company. [read post]
2 Mar 2012, 6:52 am
Aventis (?) [read post]
22 Feb 2012, 7:37 am
GmbH and Sanofi-aventis v. [read post]
22 Dec 2011, 11:59 am
Wyeth Pharmaceuticals, Inc., 15 A.3d 909 (Pa. [read post]
2 Dec 2011, 2:00 pm
Qualitest Pharmaceuticals Inc., 2011 WL 334671, at *3 (E.D. [read post]
9 Nov 2011, 9:59 pm
By Donald Zuhn -- In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file a supplemental answer, affirmative defenses, and counterclaims by… [read post]
26 Oct 2011, 9:49 am
Aventis Pharmaceuticals Inc. v. [read post]
21 Oct 2011, 2:00 am
Patent No. 6,794,410 entitled USE OF (Z) -2-CYANO-3-HYDROXY- BUT-2-ENOIC ACID-(4-TRIFLUOROMETHYLPHENYL) -AMIDE FOR TREATING MULTIPLE SCLEROSIS and owned by Aventis Pharmaceuticals. [read post]
21 Oct 2011, 2:00 am
Patent No. 6,794,410 entitled USE OF (Z) -2-CYANO-3-HYDROXY- BUT-2-ENOIC ACID-(4-TRIFLUOROMETHYLPHENYL) -AMIDE FOR TREATING MULTIPLE SCLEROSIS and owned by Aventis Pharmaceuticals. [read post]
16 Sep 2011, 11:02 am
The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
15 Sep 2011, 5:00 am
Sanofi-Aventis U.S. [read post]
10 Aug 2011, 4:30 am
(Patent Docs) Prezista (Darunavir) – US: Patent infringement complaint filed following a Paragraph IV certification: Tibotec Inc. et al. v. [read post]
3 Aug 2011, 3:31 am
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs) Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC… [read post]
10 Jul 2011, 11:29 pm
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
8 Jul 2011, 11:04 am
IMS Health Inc., ___ U.S. ___, 2011 WL 2472796, at *8 (U.S. [read post]
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
9 Jun 2011, 10:02 am
Biomet, Inc., 2008 WL 2329132, at *6 (W.D. [read post]
